TransMedics Cost Of Revenue vs Other Operating Expenses Analysis

TMDX Stock  USD 76.04  3.30  4.16%   
TransMedics financial indicator trend analysis is much more than just breaking down TransMedics Group prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether TransMedics Group is a good investment. Please check the relationship between TransMedics Cost Of Revenue and its Other Operating Expenses accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TransMedics Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Cost Of Revenue vs Other Operating Expenses

Cost Of Revenue vs Other Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of TransMedics Group Cost Of Revenue account and Other Operating Expenses. At this time, the significance of the direction appears to have totally related.
The correlation between TransMedics' Cost Of Revenue and Other Operating Expenses is 0.99. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of TransMedics Group, assuming nothing else is changed. The correlation between historical values of TransMedics' Cost Of Revenue and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of TransMedics Group are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Cost Of Revenue i.e., TransMedics' Cost Of Revenue and Other Operating Expenses go up and down completely randomly.

Correlation Coefficient

0.99
Relationship DirectionPositive 
Relationship StrengthVery Strong

Cost Of Revenue

Cost of Revenue is found on TransMedics Group income statement and represents the costs associated with goods and services TransMedics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of TransMedics Group. It is also known as TransMedics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most indicators from TransMedics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into TransMedics Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TransMedics Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
At this time, TransMedics' Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 0.96 in 2024, despite the fact that Tax Provision is likely to grow to (1.4 M).
 2021 2022 2023 2024 (projected)
Total Operating Expenses60.6M96.7M182.8M192.0M
Research Development22.3M26.8M36.1M22.2M

TransMedics fundamental ratios Correlations

0.980.7-0.090.81-0.750.860.99-0.120.98-0.370.990.941.00.610.910.960.990.72-0.090.980.980.960.640.98-0.09
0.980.7-0.160.8-0.80.920.96-0.060.97-0.370.990.950.980.640.930.980.980.73-0.040.970.970.940.650.97-0.03
0.70.7-0.120.93-0.740.470.690.060.59-0.080.730.530.730.960.830.820.70.87-0.240.60.580.520.160.580.01
-0.09-0.16-0.120.00.12-0.36-0.08-0.44-0.170.17-0.14-0.2-0.07-0.090.01-0.15-0.110.240.35-0.16-0.13-0.14-0.34-0.14-0.35
0.810.80.930.0-0.750.580.79-0.270.71-0.050.820.660.850.860.890.870.810.84-0.20.720.710.650.270.71-0.3
-0.75-0.8-0.740.12-0.75-0.69-0.720.01-0.660.01-0.81-0.66-0.78-0.79-0.82-0.82-0.73-0.790.01-0.66-0.65-0.6-0.27-0.650.02
0.860.920.47-0.360.58-0.690.82-0.020.9-0.320.880.870.840.440.750.840.850.48-0.150.90.890.880.750.890.02
0.990.960.69-0.080.79-0.720.82-0.080.96-0.50.980.930.980.590.930.941.00.71-0.070.960.960.940.560.96-0.04
-0.12-0.060.06-0.44-0.270.01-0.02-0.08-0.05-0.31-0.06-0.07-0.140.1-0.1-0.02-0.080.0-0.04-0.05-0.08-0.040.06-0.070.98
0.980.970.59-0.170.71-0.660.90.96-0.05-0.420.970.970.960.490.830.920.970.62-0.071.01.01.00.771.0-0.01
-0.37-0.37-0.080.17-0.050.01-0.32-0.5-0.31-0.42-0.36-0.46-0.340.02-0.39-0.32-0.45-0.12-0.16-0.42-0.44-0.44-0.14-0.44-0.43
0.990.990.73-0.140.82-0.810.880.98-0.060.97-0.360.950.990.660.930.980.980.75-0.050.970.970.940.620.97-0.03
0.940.950.53-0.20.66-0.660.870.93-0.070.97-0.460.950.920.450.810.910.940.590.120.970.970.970.740.97-0.03
1.00.980.73-0.070.85-0.780.840.98-0.140.96-0.340.990.920.650.930.960.990.75-0.10.960.960.930.590.96-0.12
0.610.640.96-0.090.86-0.790.440.590.10.490.020.660.450.650.770.760.60.9-0.180.50.480.420.080.480.05
0.910.930.830.010.89-0.820.750.93-0.10.83-0.390.930.810.930.770.950.920.870.010.840.850.790.330.84-0.06
0.960.980.82-0.150.87-0.820.840.94-0.020.92-0.320.980.910.960.760.950.950.830.00.930.920.890.570.920.0
0.990.980.7-0.110.81-0.730.851.0-0.080.97-0.450.980.940.990.60.920.950.71-0.10.980.980.950.610.97-0.05
0.720.730.870.240.84-0.790.480.710.00.62-0.120.750.590.750.90.870.830.710.090.630.620.570.150.620.02
-0.09-0.04-0.240.35-0.20.01-0.15-0.07-0.04-0.07-0.16-0.050.12-0.1-0.180.010.0-0.10.09-0.07-0.05-0.04-0.09-0.050.05
0.980.970.6-0.160.72-0.660.90.96-0.051.0-0.420.970.970.960.50.840.930.980.63-0.071.00.990.761.0-0.01
0.980.970.58-0.130.71-0.650.890.96-0.081.0-0.440.970.970.960.480.850.920.980.62-0.051.00.990.751.0-0.03
0.960.940.52-0.140.65-0.60.880.94-0.041.0-0.440.940.970.930.420.790.890.950.57-0.040.990.990.81.00.01
0.640.650.16-0.340.27-0.270.750.560.060.77-0.140.620.740.590.080.330.570.610.15-0.090.760.750.80.760.06
0.980.970.58-0.140.71-0.650.890.96-0.071.0-0.440.970.970.960.480.840.920.970.62-0.051.01.01.00.76-0.02
-0.09-0.030.01-0.35-0.30.020.02-0.040.98-0.01-0.43-0.03-0.03-0.120.05-0.060.0-0.050.020.05-0.01-0.030.010.06-0.02
Click cells to compare fundamentals

TransMedics Account Relationship Matchups

TransMedics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets105.3M152.0M134.9M277.1M706.0M741.3M
Total Current Liabilities16.1M11.9M23.2M23.7M54.9M57.7M
Total Stockholder Equity54.6M103.9M67.9M187.4M137.2M144.1M
Other Liab1.1M759K389K1.6M1.4M901.6K
Net Tangible Assets54.6M103.9M67.9M187.4M215.5M226.3M
Retained Earnings(369.5M)(398.2M)(442.4M)(478.7M)(503.7M)(528.9M)
Accounts Payable7.2M1.2M6.7M3.3M12.7M13.4M
Cash20.1M24.6M25.6M201.2M394.8M414.6M
Long Term Debt34.1M34.7M35.2M58.7M506.2M531.5M
Inventory11.2M11.9M14.9M20.6M44.2M46.4M
Total Liab50.7M48.1M67.0M89.8M568.8M597.3M
Total Current Assets100.0M146.8M118.7M252.3M510.7M536.2M
Common Stock424.1M502.2M510.5M666.3M641.1M375.9M
Property Plant Equipment4.8M4.8M15.7M24.4M28.0M29.4M
Other Current Liab8.7M10.4M16.3M17.2M36.2M38.0M
Net Receivables6.6M6.9M5.9M27.6M63.6M66.8M
Common Stock Shares Outstanding14.2M24.7M27.6M29.6M32.5M24.3M
Other Stockholder Equity(105.3M)(95K)68.0M(225K)(202.5K)(192.4K)
Short Long Term Debt Total34.1M34.7M43.8M67.6M515.9M541.7M
Property Plant And Equipment Net4.8M4.8M15.7M24.4M180.5M189.5M
Current Deferred Revenue166K263K250K241K2.0M2.1M
Net Debt14.1M10.1M(17.0M)(133.6M)121.1M127.2M
Non Current Assets Total5.3M5.3M16.2M24.9M195.4M205.2M
Cash And Short Term Investments80.7M125.6M92.5M201.2M394.8M414.6M
Common Stock Total Equity331.2M424.1M502.2M510.5M587.1M389.0M
Long Term Debt Total33.7M34.1M34.7M35.2M40.5M31.8M
Liabilities And Stockholders Equity105.3M152.0M134.9M277.1M706.0M741.3M
Non Current Liabilities Total34.5M36.3M43.8M66.1M513.9M539.6M
Other Current Assets1.5M4.7M5.5M2.9M8.0M8.4M
Net Invested Capital88.8M138.5M103.1M246.1M643.4M675.6M
Property Plant And Equipment Gross4.8M4.8M15.7M24.4M201.8M211.9M
Accumulated Other Comprehensive Income(2K)(95K)(188K)(225K)(199K)(209.0K)
Net Working Capital83.9M134.9M95.5M228.6M455.7M478.5M
Capital Stock424.1M502.2M510.5M666.3M641.1M563.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for TransMedics Stock Analysis

When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.